$DGX News

Quest Diagnostics (NYSE:DGX) Shows Dividend Quality Beyond the Headline Yield

Quest Diagnostics Declares Quarterly Cash Dividend

Is Quest Diagnostics (DGX) A Bargain Following Raised Guidance And Strong Quarterly Results?

Quest Diagnostics (DGX) Stock May Be 32% Undervalued As Guidance Rises

Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?

Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026

Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics

JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $250

Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks

Quest Diagnostics (DGX) Stock Gets Fair Value Boost After Q2 Beat And Higher Guidance

Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $260

Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $250

Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?

Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $250

Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $255

Quest Diagnostics Upgrades EPS Outlook For 2026 After Outperforming Q2 Results

Quest Diagnostics Incorporated Q2 2026 Earnings Call Summary

Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

Quest Diagnostics Q2 Earnings Call Highlights

Quest Diagnostics Incorporated (DGX) Q2 2026 Earnings Call Transcript